Saltar al contenido
Radio Logo
PodcastsCienciasHematologic Oncology Update

Hematologic Oncology Update

Dr. Neil Love
Último episodio

178 episodios

  • Hematologic Oncology Update

    GPRC5D-Directed Therapies for Multiple Myeloma — An Interview with Prof Rakesh Popat

    21/11/2026 | 55 min
    Featuring an interview with Prof Rakesh Popat, including the following topics:
    Overview of GPRC5D and its clinical significance (0:00)
    Key findings from Phase II TALisman study regarding dysgeusia assessment for patients receiving talquetamab (2:30)
    Mitigating dysgeusia and dry mouth arising from GPRC5D-directed therapy (6:25)
    Key findings from the Phase III MonumenTAL-3 study (11:49)
    Selection factors for GPRC5D- and BCMA-directed therapies (15:16)
    Managing extramedullary multiple myeloma (MM) with GPRC5D-targeted therapies and beyond (18:30)
    Key findings with arlocabtagene autoleucel (arlo-cel) for relapsed/refractory (R/R) MM (20:47)
    Ramantamig and other GPRC5D-targeted approaches (25:32)
    Comparing arlo-cel to ciltacabtagene autoleucel for MM; CNS issues with GPRC5D-directed therapies (28:42)
    Case: A man in his late 70s with a history of chronic obstructive pulmonary disease and t(4;14) R/R MM who receives fourth-line talquetamab and attains a very good partial response (38:27)
    Cases: A man in his late 40s with t(11;14), del(17p) R/R MM who enrolls in the Phase II QUINTESSENTIAL-2 study for third-line treatment; a man in his late 60s with t(11;14), del(17p) MM and early relapse after third-line autologous stem cell transplant (45:18)
    Guidance on sequencing BCMA- and GPRC5D-directed therapies (47:35)
    Importance of tumor debulking; access to arlo-cel (52:27)

    CME information and select publications
  • Hematologic Oncology Update

    Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on The Utility of Tafasitamab

    16/11/2026 | 15 min
    Featuring an interview with Dr Matthew Lunning, including the following topics:
    Tafasitamab for follicular lymphoma (0:00)
    frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51)

    CME information and select publications
  • Hematologic Oncology Update

    Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies

    14/11/2026 | 57 min
    Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics:
    Introduction (0:00)
    Prologue: Saturday Night Fever (1:35)
    Baby Boomers' Guide to Mechanisms of Action (3:07)
    Second-Line Treatment (12:36)
    Complications Associated with Bispecific Antibodies (23:41)
    Case Presentations (25:52)
    New Bispecific T-Cell Engagers — Surovatamig (26:24)
    Other Novel Agents (50:05)

    CME information and select publications
  • Hematologic Oncology Update

    Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

    11/11/2026 | 1 h 2 min
    Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics:
    Multiple Myeloma (0:00)
    Introduction: ESMO 2026; Recent FDA Approvals (1:53)
    Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46)
    Bispecific Antibodies — Dr Lonial (19:16)
    Antibody-Drug Conjugates — Dr Richardson (37:08)
    Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10)

    CME information and select publications
  • Hematologic Oncology Update

    Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 2: An Interview with Dr Matthew Lunning on Novel Combination Regimens

    06/11/2026 | 17 min
    Featuring an interview with Dr Matthew Lunning, including the following topics:
    Bispecific antibody/antibody-drug conjugate combinations (0:00)
    A man in his late 90s with mantle cell lymphoma — Ann LaCasce, MD, MMSc (8:07)

    CME information and select publications
Más podcasts de Ciencias
Acerca de Hematologic Oncology Update
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
Sitio web del podcast

Escucha Hematologic Oncology Update, Masaje Cerebral y muchos más podcasts de todo el mundo con la aplicación de radio.net

Descarga la app gratuita: radio.net

  • Añadir radios y podcasts a favoritos
  • Transmisión por Wi-Fi y Bluetooth
  • Carplay & Android Auto compatible
  • Muchas otras funciones de la app
Hematologic Oncology Update: Podcasts del grupo